{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:01:35Z","timestamp":1791396095125,"version":"4.3.3"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T00:00:00Z","timestamp":1362614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives and methods<\/jats:title><jats:p>Chronic myelomonocytic leukemia (<jats:styled-content style=\"fixed-case\">CMML<\/jats:styled-content>) is a severe disease for which allogeneic stem cell transplantation (allo\u2010<jats:styled-content style=\"fixed-case\">SCT<\/jats:styled-content>) remains the only potentially curative treatment. We describe a retrospective study determining prognostic factors for outcome after allo\u2010<jats:styled-content style=\"fixed-case\">SCT<\/jats:styled-content> in consecutive 73 patients with <jats:styled-content style=\"fixed-case\">CMML<\/jats:styled-content> reported to the <jats:styled-content style=\"fixed-case\">SFGM<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">TC<\/jats:styled-content> registry between 1992 and 2009.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At diagnosis, median age was 53\u00a0yrs, and 36% patients had palpable splenomegaly (SPM). 48, 13, and 9 patients had good, intermediate, and poor risk karyotype, respectively, according to <jats:styled-content style=\"fixed-case\">IPSS<\/jats:styled-content>, 61% patients had <jats:styled-content style=\"fixed-case\">CMML<\/jats:styled-content>\u20101, and 39% had <jats:styled-content style=\"fixed-case\">CMML<\/jats:styled-content>\u20102. 41\/31\/1 cases had an HLA\u2010identical sibling, an unrelated and haploidentical donor, respectively. 43 patients received reduced\u2010intensity conditioning. With a median follow\u2010up of 23\u00a0month, acute grade 2\u20134 and chronic <jats:styled-content style=\"fixed-case\">GVHD<\/jats:styled-content> developed in 21 and 25 patients, respectively. The 3\u2010year OS, <jats:styled-content style=\"fixed-case\">NRM<\/jats:styled-content> (non\u2010relapse mortality),<jats:styled-content style=\"fixed-case\">EFS<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">CIR<\/jats:styled-content> (cumulative incidence of relapse) were 32%, 36%, 29% and 35%, respectively. <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content> was not influenced by the <jats:styled-content style=\"fixed-case\">CR<\/jats:styled-content> status, marrow blasts% at allo\u2010SCT, prior treatments, and <jats:styled-content style=\"fixed-case\">cGVHD<\/jats:styled-content>. Using multivariate analysis, year of transplant\u00a0&lt;\u00a02004 (<jats:styled-content style=\"fixed-case\">YOT<\/jats:styled-content>) (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.005) was associated with higher <jats:styled-content style=\"fixed-case\">NRM<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> YOT<\/jats:styled-content>\u00a0&lt;\u00a02004 (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.04) and <jats:styled-content style=\"fixed-case\">SPM<\/jats:styled-content> at allo\u2010<jats:styled-content style=\"fixed-case\">SCT<\/jats:styled-content> (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.02) with lower <jats:styled-content style=\"fixed-case\">EFS<\/jats:styled-content>, and <jats:styled-content style=\"fixed-case\">YOT<\/jats:styled-content>\u00a0&lt;\u00a02004 (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.03) and <jats:styled-content style=\"fixed-case\">SPM<\/jats:styled-content> at allo\u2010<jats:styled-content style=\"fixed-case\">SCT<\/jats:styled-content> (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.04) with poorer <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Allogeneic stem cell transplantation is a valid treatment option for patients with <jats:styled-content style=\"fixed-case\">CMML<\/jats:styled-content>, and its outcome has improved with <jats:styled-content style=\"fixed-case\">YOT<\/jats:styled-content>\u00a0&gt;\u00a02004. Splenomegaly seems to be a negative factor of <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">EFS<\/jats:styled-content> in this series.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ejh.12073","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T10:53:17Z","timestamp":1358333597000},"page":"355-364","source":"Crossref","is-referenced-by-count":72,"title":["Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire"],"prefix":"10.1111","volume":"90","author":[{"given":"Sophie","family":"Park","sequence":"first","affiliation":[{"name":"Hematology H\u00f4pital Cochin Universit\u00e9 Paris V Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Labopin","sequence":"additional","affiliation":[{"name":"ALWP EBMT\u2010Paris Office H\u00f4pital Saint Antoine AP\u2010HP Universit\u00e9 Pierre et Marie Curie Paris 6 Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Yakoub\u2010Agha","sequence":"additional","affiliation":[{"name":"UAM Allogreffes de CSH Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Delaunay","sequence":"additional","affiliation":[{"name":"CHU Nantes Universit\u00e9 Nantes Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Dhedin","sequence":"additional","affiliation":[{"name":"Hematology Transplantation Saint Louis Hospital Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Deconinck","sequence":"additional","affiliation":[{"name":"Hematology CHU Besancon Besancon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricette","family":"Michallet","sequence":"additional","affiliation":[{"name":"Hematology Hopital Edouard Herriot HCL Universite Lyon 1 Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Robin","sequence":"additional","affiliation":[{"name":"Hematology\u2010Transplantation Saint\u2010Louis Hospital Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"De Revel","sequence":"additional","affiliation":[{"name":"Department of hematology Percy hospital Clamart France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bernard","sequence":"additional","affiliation":[{"name":"Service d'h\u00e9matologie H\u00f4pital Sud de Pontchaillou Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Vey","sequence":"additional","affiliation":[{"name":"Hopital Paoli\u2010Calmettes Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lioure","sequence":"additional","affiliation":[{"name":"CHU Strasbourg Strasbourg France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Lapusan","sequence":"additional","affiliation":[{"name":"Hematology Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Tabrizi","sequence":"additional","affiliation":[{"name":"Hematology CHU Bordeaux Pessac France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Henri","family":"Bourhis","sequence":"additional","affiliation":[{"name":"Hematology Institut Gustave Roussy Villejuif France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Huynh","sequence":"additional","affiliation":[{"name":"H\u00f4pital Purpan Universit\u00e9 Toulouse Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Beguin","sequence":"additional","affiliation":[{"name":"University of Li\u00e8ge Li\u00e8ge Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Soci\u00e9","sequence":"additional","affiliation":[{"name":"Hematology\u2010Transplantation Saint\u2010Louis Hospital Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Dreyfus","sequence":"additional","affiliation":[{"name":"Hematology H\u00f4pital Cochin Universit\u00e9 Paris V Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Fenaux","sequence":"additional","affiliation":[{"name":"H\u00f4pital Avicenne AP\u2010HP Universit\u00e9 Paris 13 Bobigny France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[{"name":"CHU Nantes Universit\u00e9 Nantes Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"605","article-title":"Chronic myelomonocytic leukemia in adults","volume":"45","author":"Baudard M","year":"1997","journal-title":"Pathol Biol (Paris)"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500305448"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2005.07.012"},{"key":"e_1_2_7_5_1","first-page":"218","article-title":"Chronic myelomonocytic leukemia: myeloproliferative variant","volume":"3","author":"Onida F","year":"2004","journal-title":"Curr Hematol Rep"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1988.6.9.1417"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819042000207271"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.7.2480.bloodjournal8872480"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.9245"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25759"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.08061.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.08.004"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02133.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.09.018"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.05.008"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.375"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03552.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705369"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704472"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-209262"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.6.2079"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.07.004"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-352039"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.840"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705727"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.366"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.134"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.048231"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-224352"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.030957"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-311019"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08381.x"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fejh.12073","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.12073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T11:26:51Z","timestamp":1700652411000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.12073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,7]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1111\/ejh.12073"],"URL":"https:\/\/doi.org\/10.1111\/ejh.12073","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,7]]}}}